非常规 T 细胞在泌尿系统肿瘤中:能抓住就抓住
Unconventional T cells in urological cancers: catch them if you can.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer.
Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肌层浸润性膀胱癌(MIBC)以复杂的肿瘤微环境(TME)为特征,该微环境驱动侵袭性进展和治疗耐药。既往研究已强调癌症相关成纤维细胞(CAFs)和耗竭T(Tex)细胞在MIBC中的作用,但其相互作用机制仍知之甚少。
本研究对来自12例患者的19份组织样本——7份MIBC、3份非肌层浸润性膀胱癌(NMIBC)和9份正常组织样本——进行单细胞RNA测序,鉴定出13个转录上不同的成纤维细胞簇和10个功能异质性的T细胞亚群。两个干扰素(IFN)应答性成纤维细胞群体,F-ISG15(炎性CAFs)和F-POSTN(肌成纤维细胞性CAFs),被证明在MIBC TME中占主导地位。体内实验表明,Tex细胞分泌的IFN-γ极化CAFs分泌CXCL12,后者通过CXCL12-CXCR4趋化轴招募表达CXCR4的T细胞。空间分析揭示了一个双向环路:Tex来源的IFN-γ维持CAF活化,而CAF分泌的CXCL12放大Tex浸润。在临床上,活化的CAF特征与MIBC晚期疾病阶段和患者生存期缩短相关。这些发现确立CXCL12和IFN信号为关键治疗靶点,为破坏免疫抑制性TME串扰和改善MIBC患者预后提供了新策略。
Muscle-invasive bladder cancer (MIBC) is characterized by a complex tumor microenvironment (TME) that drives aggressive progression and treatment resistance. Previous studies have highlighted the roles of cancer-associated fibroblasts (CAFs) and exhausted T (Tex) cells in MIBC, but their interactive mechanisms remain poorly understood.
Here, single-cell RNA sequencing of 19 tissue samples from 12 patients-7 MIBC, 3 non-muscle-invasive bladder cancer (NMIBC), and 9 normal tissue samples-identified 13 transcriptionally distinct fibroblast clusters and 10 functionally heterogeneous T-cell subsets. Two interferon (IFN)-responsive fibroblast populations, F-ISG15 (inflammatory CAFs) and F-POSTN (myofibroblastic CAFs), were shown to predominate in the MIBC TME.
In vivo experiments demonstrated that IFN-γ secreted by Tex cells polarizes CAFs to secrete CXCL12, which recruits CXCR4-expressing T cells via the CXCL12-CXCR4 chemotactic axis. Spatial analysis revealed a bidirectional loop: Tex-derived IFN-γ sustains CAF activation, whereas CAF-secreted CXCL12 amplifies Tex infiltration. Clinically, activated CAF signatures correlate with advanced disease stages and reduced patient survival in MIBC.
These findings establish CXCL12 and IFN signaling as critical therapeutic targets, offering new strategies to disrupt immunosuppressive TME crosstalk and improve outcomes for MIBC patients.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。